Abstract
Vascularization and bone repair are accelerated by a series of gene-activated scaffolds delivering both an angiogenic and an osteogenic gene. Stem cell-mediated osteogenesis in vitro, in addition to increased vascularization and bone repair by host cells in vivo, is enhanced using all systems while the use of the nanohydroxyapatite vector to deliver both genes markedly enhances bone healing.
Keywords:
bone regeneration; collagen scaffolds; gene-activated scaffolds; mesenchymal stem cells; non-viral gene therapy.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Bone Morphogenetic Protein 2 / administration & dosage
-
Bone Morphogenetic Protein 2 / pharmacology*
-
Bone Regeneration / drug effects*
-
Collagen / pharmacology*
-
Drug Delivery Systems*
-
Durapatite / pharmacology*
-
Gene Transfer Techniques
-
Genetic Therapy*
-
Human Umbilical Vein Endothelial Cells / drug effects
-
Humans
-
Mesenchymal Stem Cells / cytology
-
Mesenchymal Stem Cells / drug effects
-
Mice
-
Neovascularization, Physiologic / drug effects
-
Polyethyleneimine / pharmacology
-
Rats
-
Tissue Scaffolds / chemistry*
-
Vascular Endothelial Growth Factor A / administration & dosage
-
Vascular Endothelial Growth Factor A / pharmacology*
-
Wound Healing / drug effects
Substances
-
Bone Morphogenetic Protein 2
-
Vascular Endothelial Growth Factor A
-
nano-hydroxyapatite-collagen
-
Polyethyleneimine
-
Collagen
-
Durapatite